Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Department of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA; Institute of Molecular Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA; Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA.
Int Immunopharmacol. 2023 Oct;123:110734. doi: 10.1016/j.intimp.2023.110734. Epub 2023 Aug 2.
Drug (e.g., acetaminophen, APAP)-associated hepatotoxicity is the major cause of acute liver failure. Emerging evidence shows that initial tissue damage caused by APAP triggers molecular and cellular immune responses, which can modulate the severity of hepatoxicity. The pro-inflammatory and cytotoxic cytokine interferon (IFN)-γ has been reported as a key molecule contributing to APAP-induced liver injury (AILI). However, its cellular source remains undetermined.
In the current study, we show that elevation of serum IFN-γ in patients with drug hepatotoxicity correlates with disease severity. Neutralization of IFN-γ in a mouse model of AILI effectively reduces hepatotoxicity. Strikingly, we reveal that IFN-γ is expressed primarily by hepatic neutrophils, not by conventional immune cells with known IFN-γ-producing capability, e.g., CD8 T cells, CD4 T cells, natural killer cells, or natural killer T cells. Upon encountering APAP-injured hepatocytes, neutrophils secrete cytotoxic IFN-γ further causing cell stress and damage, which can be abrogated in the presence of blocking antibodies for IFN-γ or IFN-γreceptor. Furthermore, removal of neutrophils in vivo substantially decreases hepatic IFN-γ levels concomitantly with reduced APAP hepatotoxicity, whereas adoptive transfer of IFN-γ-producing neutrophils confers IFN-γ mice susceptibility to APAP administration.
Our findings uncover a novel mechanism of neutrophil action in promoting AILI and provide new insights into immune modulation of the disease pathogenesis.
药物(如对乙酰氨基酚,APAP)相关的肝毒性是急性肝衰竭的主要原因。新出现的证据表明,APAP 最初引起的组织损伤会触发分子和细胞免疫反应,从而调节肝毒性的严重程度。促炎和细胞毒性细胞因子干扰素(IFN)-γ已被报道为导致 APAP 诱导的肝损伤(AILI)的关键分子。然而,其细胞来源仍未确定。
在本研究中,我们表明药物性肝毒性患者血清 IFN-γ水平升高与疾病严重程度相关。在 AILI 小鼠模型中中和 IFN-γ可有效降低肝毒性。引人注目的是,我们揭示 IFN-γ主要由肝中性粒细胞表达,而不是由具有已知 IFN-γ产生能力的常规免疫细胞(例如 CD8 T 细胞、CD4 T 细胞、自然杀伤细胞或自然杀伤 T 细胞)表达。中性粒细胞遇到 APAP 损伤的肝细胞后,会分泌细胞毒性 IFN-γ,进一步导致细胞应激和损伤,而阻断 IFN-γ或 IFN-γ受体的抗体可以阻止这种情况发生。此外,体内清除中性粒细胞可显著降低肝内 IFN-γ水平,同时降低 APAP 肝毒性,而过继转移 IFN-γ产生的中性粒细胞可使 IFN-γ 小鼠对 APAP 给药敏感。
我们的发现揭示了中性粒细胞在促进 AILI 中的新作用机制,并为疾病发病机制的免疫调节提供了新的见解。